Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Esquire Financial Holdings Inc., 2 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Esquire Financial Holdings Inc. May 30, 202479.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 29, 2026 | Esquire Financial Holdings Inc. | Open-market sale | −11,600 | $127.00 | $1,473,185 |
| Aug 7, 2026 | Esquire Financial Holdings Inc. | Option exercise | +20,000 | $12.50 | $250,000 |
| Aug 7, 2026 | Esquire Financial Holdings Inc. | Shares withheld for tax | −1,902 | $131.38 | $249,885 |
| Dec 10, 2025 | Esquire Financial Holdings Inc. | Grant or award | +1,836 | — | — |
| Aug 12, 2025 | Esquire Financial Holdings Inc. | Option exercise | +22,231 | $12.50 | $277,888 |
| Aug 12, 2025 | Esquire Financial Holdings Inc. | Shares withheld for tax | −2,839 | $97.88 | $277,881 |
| Dec 24, 2024 | Esquire Financial Holdings Inc. | Gift | −1,167 | — | — |
| Dec 24, 2024 | Esquire Financial Holdings Inc. | Gift | +1,167 | — | — |
| Dec 3, 2024 | Esquire Financial Holdings Inc. | Grant or award | +2,503 | — | — |
| Jan 30, 2024 | Esquire Financial Holdings Inc. | Gift | −2,333 | — | — |
| Jan 30, 2024 | Esquire Financial Holdings Inc. | Gift | +2,333 | — | — |
| Dec 15, 2023 | Esquire Financial Holdings Inc. | Grant or award | +4,036 | — | — |
Questions about Anthony Coelho
What boards is Anthony Coelho on?
Anthony Coelho sits on the board of Esquire Financial Holdings Inc.
How long has Anthony Coelho served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.